INTERNATIONAL BIOTECHNOLOGY TRUST PLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 215 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
INTERNATIONAL BIOTECHNOLOGY TRUST PLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$2,533,000
-20.0%
303,000
-13.4%
0.91%
-37.7%
Q3 2019$3,168,000
+96.0%
350,000
+133.3%
1.46%
+144.4%
Q2 2019$1,616,000
+253.6%
150,000
+212.5%
0.60%
+254.4%
Q1 2019$457,000
+5.8%
48,0000.0%0.17%
-36.9%
Q4 2018$432,000
-70.5%
48,000
-57.5%
0.27%
-61.5%
Q3 2018$1,464,000
-8.8%
113,0000.0%0.70%
+13.0%
Q2 2018$1,605,000
+59.9%
113,000
+113.2%
0.62%
+57.1%
Q1 2018$1,004,000
-66.9%
53,000
-71.4%
0.39%
-63.4%
Q4 2017$3,034,000
-25.9%
185,000
-32.2%
1.07%
-32.9%
Q3 2017$4,095,000273,0001.59%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
WASATCH ADVISORS LP 17,986,781$10,788,4710.07%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 254,257$12,7900.03%
Long Focus Capital Management, LLC 1,372,000$822,9260.03%
GSA CAPITAL PARTNERS LLP 559,731$3360.03%
Rokos Capital Management LLP 6,474,348$3,940,9360.03%
Golden State Equity Partners 166,265$99,7260.03%
State of Wyoming 92,360$55,3980.01%
ExodusPoint Capital Management, LP 1,890,425$1,1340.01%
ACADIAN ASSET MANAGEMENT LLC 2,927,769$1,7530.01%
Fort Sheridan Advisors LLC 53,831$32,2880.01%
View complete list of SANGAMO THERAPEUTICS INC shareholders